Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2005
06/22/2005CN1628810A Black ants and Chinese clematis containing capsule
06/22/2005CN1628792A Compound sichuan lovage rhizome tincture and its preparation process
06/22/2005CN1628783A Oral liquor containing creeping oxalis, zedoary and dahurian angelica and its preparing method
06/22/2005CN1628766A Formulation of 'Xuefu Zhuyu Decoction' and its preparation method
06/22/2005CN1628764A Creat formulation and its preparation process
06/22/2005CN1628753A Medicine for treating rheumatic and rheumatoid arthritis
06/22/2005CN1628747A Acute febrile disease treating medicine and its preparation process
06/22/2005CN1628745A Antiinflammation pain relieving liquor
06/22/2005CN1628741A Chinese medicinal compound formulation for treating arthritis
06/22/2005CN1628740A Long acting, pain stopping liquor and its preparation process
06/22/2005CN1628734A Chinese medicine for treating rheumatism, rheumatoid disease and hyperosteogeny
06/22/2005CN1628733A Chinese medicine for treating high fever and its preparation
06/22/2005CN1628723A Medicine for treating cold
06/22/2005CN1628711A Method for preparing liquor to treat gynecological inflammation
06/22/2005CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof
06/22/2005CN1628684A Medicine combination containing panax pseudo-ginseng saponin triol and preparation method thereof
06/22/2005CN1628667A Compound dried suspension of dextromethorphan and gualfenesin and preparation method thereof
06/22/2005CN1628662A Medicine with abirritation
06/22/2005CN1628648A Loxoprofen sodium sustained release preparation
06/22/2005CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
06/22/2005CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207039C Medicine for treating cerebral concussion and injuries from falls
06/22/2005CN1207037C Novel usage of Japanese honewort
06/22/2005CN1207035C Chinese medicinal vinegar pills for treating heart disease, wind damp disease and cerebrovascular disease
06/22/2005CN1207020C Plaster for treating pain and swelling
06/22/2005CN1207019C Multifunctional paster
06/22/2005CN1207009C Antirheumatic medicine and its preparing method
06/22/2005CN1207005C Rabbit skin containing bioactive substance and its use
06/22/2005CN1207001C Gentiamarin powder infection for muscle injection and intravenous injection
06/21/2005US6909014 Intermediates for the synthesis of ether compounds
06/21/2005US6909007 Steroidal pharmaceutical compounds
06/21/2005US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors
06/21/2005US6908927 Reduction physical cigarette smoking
06/21/2005US6908920 Pyrimidine derivatives
06/21/2005US6908917 Chromone derivatives as matrix metalloproteinase inhibitors
06/21/2005US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay
06/21/2005US6908611 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/21/2005CA2108068C Carbamates of rapamycin
06/21/2005CA2066304C Pharmaceutical composition for the treatment of autoimmune diseases
06/17/2005CA2479432A1 Thiazole derivatives
06/16/2005WO2005054249A1 Novel compounds
06/16/2005WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
06/16/2005WO2005054199A1 Tubulin inhibitors
06/16/2005WO2005053724A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
06/16/2005WO2005053718A1 Methods and compositions for treating inflammatory and dermatological conditions
06/16/2005WO2004048565A9 Apoptosis-associated protein and use thereof
06/16/2005WO2004033436A8 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
06/16/2005US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/16/2005US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
06/16/2005US20050131061 Angiogenesis inhibitors
06/16/2005US20050131059 Anti-cancer combinations
06/16/2005US20050131047 cardiovascular disorders
06/16/2005US20050131035 Medicaments
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131026 Bronchitis; chronic obstructive pulmonary disease; antihistamines; pneumonia
06/16/2005US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents
06/16/2005US20050131020 N-type calcium channel antagonists for the treatment of pain
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130999 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
06/16/2005US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects
06/16/2005US20050130990 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids
06/16/2005US20050130981 Compounds
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130961 Muscarinic M1 receptor agonists for pain management
06/16/2005US20050130955 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methyl cellulose solution at 37 degrees especially mixed with a polymer, such as methyl cellulose and/or hydroxypropylmethyl cellulose.
06/16/2005US20050130952 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
06/16/2005US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD)
06/16/2005US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
06/16/2005US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/16/2005US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer
06/16/2005US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
06/16/2005US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins
06/16/2005US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders
06/16/2005US20050130242 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response
06/16/2005US20050129774 Mixture with surfactant and another drug; analgesics; antiinflammatory agents
06/16/2005US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
06/16/2005US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
06/16/2005US20050126886 Method and apparatus for transferring substrates
06/16/2005DE60103627T2 SELBSTEMULGIERENDES ARZNEISTOFFVERABREICHUNGSSYSTEM, wobei das Fettmittel optional ist A self-DRUG ADMINISTRATION SYSTEM, wherein the fat means is optional
06/16/2005DE10346940B3 Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate Substituted pentanols, to their use for preparing medicaments especially anti-inflammatory agents as well as pharmaceutical compositions containing them
06/16/2005CA2857067A1 Tubulin inhibitors
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547651A1 Anti-inflammatory agents
06/16/2005CA2545422A1 Tubulin inhibitors
06/15/2005EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei
06/15/2005EP1541585A1 Cxcr4 antagonist and use thereof
06/15/2005EP1541580A1 Sulfotransferase inhibitors
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541571A1 Bicyclic unsaturated tertiary amine compound
06/15/2005EP1541570A1 Novel physiologically active substance
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541172A1 Remedy for intestinal diseases and visceral pain
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
1 ... 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 ... 1272